Author Archive: BIOtechNOW Editor

Alzheimer’s Research: Where We’ve Failed and What’s To Come

health care, medicine

Alzheimer’s disease is a rapidly growing public health crisis. Today an estimated 5.4 million Americans live with the disease and, barring the development of medical breakthroughs to prevent, stop or slow Alzheimer’s disease by 2050, the number of people age 65 and older with Alzheimer’s disease may reach as high as 16 million people. What’s more, at a cost of $236 billion a year, Alzheimer’s is the most expensive disease in the nation with an Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Is Immunotherapy the 4th Pillar of Oncology?

pmwc_2017_mv_180x110

In contrast to the three traditional pillars of cancer treatment (surgery, radiotherapy, and chemotherapy), cancer immunotherapy is a relatively young field, yet it is considered a huge game-changer – as it is in the process of changing how we treat cancer. Immunotherapy is rapidly becoming part of the toolbox for treatment of various types of cancers, in some cases already establishing a new standard of care. Take the example of melanoma which will have about 76,000 Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Astellas Expands Advocacy Engagement with Focused Outreach

astellas-web

Astellas recognizes the crucial role that patient groups play in enhancing and extending the lives of patients. Sponsoring events such as the BIO Patient and Health Advocacy Summit to be held on November 3-4 is a way the Astellas Stakeholder Engagement team is supporting that goal. Astellas’ Stakeholder Engagement team is focused on collaborating with patient advocacy groups with the aim to: build and strengthen relationships with stakeholders and influential thought leaders elevate the patient voice Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Closing the Gender Gap in Biotech through SBIR/STTR Funding

sbir-sttr

Although progress has been made, there is no denying the biotech industry continues to have a large gender gap. Women hold only 16 percent of the senior management posts at the top pharma companies, and of senior executive positions at emerging companies — the 10 companies that raised most in venture capital A rounds in 2014 — only 12 (17 percent) were filled by women.* The National Center for Advancing Translational Sciences (NCATS), part of Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Riding Coast to Coast for Cancer Patients

patient-summit-4

For 21 days in September, 80 members of Bristol-Myers Squibb’s (BMS) oncology team will cross the United States, from the Oregon coast to the New Jersey shore, as part of the third annual Coast 2 Coast 4 Cancer ride. The goal is to raise one million dollars for Stand Up To Cancer, whose collaborative “Dream Teams” of scientific researchers are working together to accelerate cancer research and provide innovative treatment to patients faster. At the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , ,